An in-depth look to TAIYEN BIOTECH CO operating, investing, and financing activities

1737 free cash flow for Q3 24 is 96.36 M TWD. For 2023, 1737 free cash flow was 184.75 M TWD and operating cash flow was 526.4 M TWD.